Research indicates that in advanced lung adenocarcinomas, suppressed AIF expression correlates with increased drug resistance via c‐Met [52], while high AIF expression in various tumours is linked to better patient survival [53, 54] and inhibition of hypoxia‐induced epithelial to mesenchymal transition [55]. The gene discussed is MET; the disease is lung adenocarcinoma.